Susquehanna International Group, LLP Next Cure, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 07, 2024
BUY
$1.13 - $2.23 $11,864 - $23,415
10,500 New
10,500 $23,000
Q3 2023

Nov 14, 2023
SELL
$1.29 - $1.84 $26,058 - $37,168
-20,200 Reduced 42.89%
26,900 $34,000
Q2 2023

Aug 11, 2023
BUY
$1.47 - $1.86 $50,127 - $63,426
34,100 Added 262.31%
47,100 $84,000
Q1 2023

May 16, 2023
BUY
$1.46 - $1.83 $18,980 - $23,790
13,000 New
13,000 $19,000
Q2 2022

Aug 15, 2022
BUY
$3.38 - $5.27 $476,918 - $743,596
141,100 Added 315.66%
185,800 $873,000
Q1 2022

May 16, 2022
SELL
$4.76 - $6.24 $179,452 - $235,248
-37,700 Reduced 45.75%
44,700 $217,000
Q4 2021

Feb 14, 2022
BUY
$5.7 - $9.1 $15,960 - $25,480
2,800 Added 3.52%
82,400 $494,000
Q3 2021

Nov 15, 2021
SELL
$6.74 - $8.02 $828,346 - $985,658
-122,900 Reduced 60.69%
79,600 $537,000
Q2 2021

Aug 11, 2021
BUY
$7.6 - $10.28 $832,960 - $1.13 Million
109,600 Added 117.98%
202,500 $1.63 Million
Q1 2021

May 17, 2021
SELL
$9.81 - $13.88 $667,080 - $943,840
-68,000 Reduced 42.26%
92,900 $930,000
Q4 2020

Feb 16, 2021
BUY
$9.47 - $12.43 $418,574 - $549,406
44,200 Added 37.87%
160,900 $1.75 Million
Q3 2020

Nov 16, 2020
BUY
$8.15 - $21.17 $951,105 - $2.47 Million
116,700 New
116,700 $1.03 Million

Others Institutions Holding NXTC

# of Institutions
50
Shares Held
16M
Call Options Held
1.4K
Put Options Held
0
View Full List

About NextCure, Inc.

NXTC Quotes by TradingView
  • Ticker NXTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,748,800
  • Market Cap $37.5M
  • Description
  • NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...
More about NXTC
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email